TLR4 and fatty liver disease: Conversely, mice harboring inactivating mutations in TLR4 or TNF- α receptor I (TNFRI) are protected against alcohol-mediated gut barrier disruption, hepatic steatosis, and progression ALD (Uesugi et al., 2001; Chen et al., 2015).